BlackRock’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.35B | Buy |
|
|||||
2025
Q1 | $3.97B | Buy |
|
|||||
2024
Q4 | $4.04B | Sell |
|
|||||
2024
Q3 | $3.6B | Buy |
|
|||||
2024
Q2 | $4.71B | Sell |
|
|||||
2024
Q1 | $5.01B | Buy |
|
|||||
2023
Q4 | $3.98B | Buy |
|
|||||
2023
Q3 | $3.56B | Buy |
|
|||||
2023
Q2 | $4.79B | Sell |
|
|||||
2023
Q1 | $4.28B | Sell |
|
|||||
2022
Q4 | $3.96B | Buy |
|
|||||
2022
Q3 | $4.33B | Sell |
|
|||||
2022
Q2 | $5.3B | Sell |
|
|||||
2022
Q1 | $6.71B | Sell |
|
|||||
2021
Q4 | $7.39B | Buy |
|
|||||
2021
Q3 | $6B | Buy |
|
|||||
2021
Q2 | $5.47B | Sell |
|
|||||
2021
Q1 | $4.78B | Sell |
|
|||||
2020
Q4 | $5.35B | Sell |
|
|||||
2020
Q3 | $4.71B | Sell |
|
|||||
2020
Q2 | $4.11B | Buy |
|
|||||
2020
Q1 | $3.52B | Buy |
|
|||||
2019
Q4 | $4.25B | Buy |
|
|||||
2019
Q3 | $3.64B | Buy |
|
|||||
2019
Q2 | $3.05B | Sell |
|
|||||
2019
Q1 | $3.29B | Buy |
|
|||||
2018
Q4 | $2.52B | Buy |
|
|||||
2018
Q3 | $2.66B | Sell |
|
|||||
2018
Q2 | $2.25B | Sell |
|
|||||
2018
Q1 | $2.18B | Buy |
|
|||||
2017
Q4 | $1.74B | Buy |
|
|||||
2017
Q3 | $1.65B | Buy |
|
|||||
2017
Q2 | $1.67B | Buy |
|
|||||
2017
Q1 | $1.32B | Buy |
|
|||||
2016
Q4 | $57.4M | Buy |
|
|||||
2016
Q3 | $69.6M | Sell |
|
|||||
2016
Q2 | $61.2M | Buy |
|
|||||
2016
Q1 | $43.4M | Sell |
|
|||||
2015
Q4 | $48.7M | Sell |
|
|||||
2015
Q3 | $75.9M | Buy |
|
|||||
2015
Q2 | $74.9M | Sell |
|
|||||
2015
Q1 | $79.3M | Buy |
|
|||||
2014
Q4 | $48.5M | Buy |
|
|||||
2014
Q3 | $32.4M | Buy |
|
|||||
2014
Q2 | $26.8M | Sell |
|
|||||
2014
Q1 | $24.1M | Sell |
|
|||||
2013
Q4 | $30.3M | Buy |
|
|||||
2013
Q3 | $22.6M | Buy |
|
|||||
2013
Q2 | $15.7M | Buy |
|